Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET/CT.

Autor: Secerov-Ermenc A; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Peterlin P; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Anderluh F; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., But-Hadzic J; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Jeromen-Peressutti A; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Velenik V; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Segedin B; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Publikováno v: Radiology and oncology [Radiol Oncol] 2024 Oct 04; Vol. 58 (4), pp. 580-587. Date of Electronic Publication: 2024 Oct 04 (Print Publication: 2024).

PO-1297 Neoadjuvant chemoradiotherapy for esophageal cancer – a single institution experience

Autor: Secerov Ermenc, A., Anderluh, F., Jeromen Peressutti, A., Velenik, V., Oblak, I., Korosec, P., But Hadzic, J., Pulko, N.

Publikováno v: In Radiotherapy and Oncology May 2022 170 Supplement 1:S1095-S1095

P-175 Total neoadjuvant treatment versus standard therapy (neoadjuvant radiochemotherapy and adjuvant chemotherapy) of rectal cancer with high-risk factors for local or systemic recurrence

Autor: Tuta, M., Boc, N., Peternel, M., Anderluh, F., Oblak, I., Secerov-Ermenc, A., Peressutti, A. Jeromen, Brecelj, E., Velenik, V.

Publikováno v: In Annals of Oncology July 2020 31 Supplement 3:S147-S147

P-319 - Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer

Autor: Velenik, V., Omejc, M., Ocvirk, J., Edhemović, I., Anderluh, F., Oblak, I., But-Hadzic, J.

Publikováno v: In Annals of Oncology June 2018 29 Supplement 5:v89-v90

Definitive radiochemotherapy in esophageal cancer - a single institution experience.

Autor: Anderluh F; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia., Toplak M; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia., Velenik V; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia., Oblak I; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia., Ermenc AS; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia., Peressutti AJ; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia., But-Hadzic J; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia., Vidmar MS; Department of Radiotherapy, Institute of Oncology Ljubljana;Ljubljana, Slovenia.

Publikováno v: Radiology and oncology [Radiol Oncol] 2019 Nov 20; Vol. 53 (4), pp. 480-487. Date of Electronic Publication: 2019 Nov 20.